When it comes to injectable drug products, purity isn’t just about the formulation — it’s also about what shouldn’t be there. USP <788>, established by the United States Pharmacopeia, is the industry standard for detecting and controlling subvisible particulate matter in injection solutions. It plays a vital role in protecting patient safety and ensuring drug efficacy across pharmaceutical, biotech, and medical applications.
What Is USP <788>?
USP <788> outlines procedures for determining the count and size of undissolved particles in injections. It specifically targets particles ≥ 10 µm and ≥ 25 µm and applies to two types of injection formats:
- Large Volume Parenterals (LVP): > 100 mL
- Small Volume Parenterals (SVP): ≤ 100 mL
The standard provides two primary testing methods:
Method 1 – Light Obscuration
The most commonly used method, ideal for clear solutions, utilizing laser-based detection.
Method 2 – Microscopic Particle Count
Used when Method 1 exceeds acceptable particle limits or for opaque/emulsion samples.
USP <788> Particle Limits
Depending on the container volume and test method, USP <788> defines strict particle limits:
| Method 1 (e.g., Beckman® HAIC) | Method 2 (e.g., Halo Labs Aura®) | |||
|---|---|---|---|---|
| Particle equivalent diameter | ≥ 10 µm | ≥ 25 µm | ≥ 10 µm | ≥ 25 µm |
| Container > 100 mL | ≤ 25 per mL | ≤ 3 per mL | ≤ 12 per mL | ≤ 2 per mL |
| Container ≤ 100 mL | ≤ 6,000 per container | ≤ 600 per container | ≤ 3,000 per container | ≤ 300 per container |
These limits are harmonized with the European Pharmacopoeia (EP) and Japanese Pharmacopoeia (JP) to support global regulatory compliance.
Why USP <788> Matters
Subvisible particles may not be visible to the naked eye, but they can:
- Trigger immune responses in patients
- Affect drug stability and shelf life
- Compromise the integrity of injectable products
By adhering to USP <788>, pharmaceutical manufacturers help ensure the highest levels of product quality and patient safety.
C&G Containers & USP <788> Compliance
At C&G Containers, we support USP <788> compliance by offering:
- A range of container types and sizes suitable for LVP and SVP
- Certified clean packaging ideal for particulate-sensitive applications
- Documentation including Certificates of Analysis and Certificates of Process
Whether you’re developing a parenteral drug, conducting clinical trials, or manufacturing for commercial use, our products are engineered to meet stringent particulate requirements.
Download the flier for a quick reference guide to USP <788> container types, limits, and compliance information.